Home > PE Ratio > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of PAR DRUGS AND CHEMICALS is 8.11.

Share Price ₹86.4May 22,2026
Market Cap ₹106.2 Cr
Earnings-TTM₹13.1 CrTTM-Standalone Results
Price/Earnings8.11xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of PAR DRUGS AND CHEMICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of PAR DRUGS AND CHEMICALS is calculated as :

Current Market Cap [ ₹106.2 Cr] as on May 22,2026

(/) Earnings [ ₹13.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 8.11x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for PAR DRUGS AND CHEMICALS , the investors are currently willing to pay 8.11 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PAR DRUGS AND CHEMICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of PAR DRUGS AND CHEMICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of PAR DRUGS AND CHEMICALS


PE Ratio Performance Analysis for PAR DRUGS AND CHEMICALS

- PAR DRUGS AND CHEMICALS 's latest p/e ratio is 8.11x.

- PAR DRUGS AND CHEMICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.18x.

- PAR DRUGS AND CHEMICALS 's operated at median p/e ratio of 15.2x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PAR DRUGS AND CHEMICALS 's p/e ratio peaked in Mar2022 at 21.34x.

- PAR DRUGS AND CHEMICALS 's p/e ratio hit its five-year low in Mar2021 of 3.28x.


How does PAR DRUGS AND CHEMICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
PAR DRUGS AND CHEMICALS 13.118.11106.2
SUN PHARMACEUTICAL INDUSTRIES LTD11,564.5038.28442,725.0
DIVIS LABORATORIES LTD2,479.0073.73182,775.0
TORRENT PHARMACEUTICALS LTD2,138.0070.98151,764.0
CIPLA LTD3,869.7929.20113,007.0
DR REDDYS LABORATORIES LTD4,144.2026.33109,098.0
MANKIND PHARMA LTD1,926.4153.17102,422.0
LUPIN LTD5,355.4719.46104,222.0
ZYDUS LIFESCIENCES LTD5,026.4020.80104,543.0
AUROBINDO PHARMA LTD3,501.4524.0784,272.7
LAURUS LABS LTD889.8581.5072,518.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PAR DRUGS AND CHEMICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 8.11x
Max industry PE 81.50x
Median industry PE 29.20x
Average industry PE 40.51x



You may also like the below Video Courses